Now that Roche Holdings AG and Genentech Inc. have (finally) reached a merger agreement, bringing an end to the hostile bidding and rampant speculation, industry observers are left to wonder what sort of ripple effect the deal might have on the overall biotech landscape. (BioWorld Today) Read More
